EARNINGS (LOSS) PER SHARE (Tables)

3 Months Ended

Mar. 31, 2024

The reconciliations of the net loss and the weighted average number of shares used in the computations of basic and diluted loss per share are as follows:


	Three Months Ended March 31,
	2024		2023
Numerator:
Net loss and comprehensive loss	$	(18,355)	$	(12,440)


Net loss and comprehensive loss - diluted	$	(18,355)	$	(12,440)

Denominator:
Weighted-average shares of common stock - basic	195,131,642		194,050,835

Weighted-average shares of common stock - diluted	195,131,642		194,050,835

Loss per common share:
Basic	$	(0.09)	$	(0.06)
Diluted	$	(0.09)	$	(0.06)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table summarizes weighted average instruments that may, in the future, have a dilutive effect on earnings (loss) per share, but were excluded from consideration in the computation of diluted net loss per share for the three months ended March 31, 2024 and 2023, because the impact of including them would have been anti-dilutive:


	Three Months Ended March 31,
	2024	2023
Stock options	27,653,611	28,615,308
Warrants (derivative liabilities and equity)	88,052,437	85,989,948
Unvested restricted stock awards	1,861	1,120,815
	115,707,909	115,726,071